Our Vision:

Published in the Journal of Clinical Oncology, the peer-reviewed article, “International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma” is a collaborative effort among the world’s finest myeloma researchers and experts to provide “the first consensus definition of high-risk multiple myeloma in the contemporary era of genomics.” Among the authors of the peer-reviewed article are IMF Chairperson of the Board S. Vincent Rajkumar, MD; and IMF Scientific Advisory Board Members: IMWG Scientific Committee Member and IMS Past President Nikhil Munshi, MD (Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute—Boston, MA); IMS President, IMWG Scientific and Steering Committee Member Philippe Moreau, MD (University Hospital of Nantes — Nantes, France); Saad Z. Usmani, MD, MBA, FACP, FASCO (Memorial Sloan Kettering Cancer Center — New York, NY); Asian Myeloma Network Executive Committee Chairperson Wee Joo Chng, MD (National University Cancer Institute, National University Health System; and National University of Singapore—Singapore); Sagar Lonial MD, FACP (Winship Cancer Institute, Emory University — Atlanta, GA); María-Victoria Mateos, MD, PhD (University of Salamanca — Salamanca, Spain); and Shaji Kumar, MD (Mayo Clinic — Rochester, MN). To learn more, read the news release. READ THE NEWS RELEASE.

On Tuesday, July 29, 2025, the IMF will host a Virtual Myeloma Community Workshop at 3:00 p.m. | 4:00 p.m.MT | 5:00 p.m CT |  6:00 p.m. ET.  This workshop will focus on topics concerning relapsed/refractory myeloma patients. This second installment in a three-part series focuses on myeloma treatment options at the time of relapse.The workshops's speakers include IMF Senior Vice President of Patient Support Robin Tuohy; IMF Chief Medical Officer Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO (TGen at the City of Hope — Phoenix); Brea Lipe, MD, Clinical Director, Myeloma Program at James P. Wilmot Cancer Center (University of Rochester Medical Center — Rochester, NY); Yi Lin, MD, PhD, (Mayo Clinic—Rochester, MN); and IMF Nurse Leadership Board Member Rebecca Lu, MSN, FNP-C (MD Anderson Cancer Center — Houston).  REGISTER NOW.

Along with an expert patient panel, IMF Chief Medical Officer Dr. Joseph Mikhael will discuss Top Myeloma Research presented at the June 2025 American Society of Clinical Oncology (ASCO) Annual Conference, the IMF International Myeloma Working Group (IMWG) Summit, and the European Hematology Association (EHA) Annual Conference on Tuesday, July 1, at 3:00 p.m. PST | 6:00 p.m. EST. During this webinar, Dr. Mikhael will highlight scientific abstracts from the June 2025 ASCO Annual Conference, the IMF IMWG Summit, and the EHA Annual Conference and will explain data in approachable terms that patients can use in their everyday care decision-making.   

To provide insights on the patient perspective of this data, the webinar’s panelists will include Myeloma Research Advocate and City of Hope Support Group Leader Todd Kennedy, President of Myeloma Patients Europe and Patient Advocate Barbara Leonardi, and Founder and Support Group Leader of the Connecticut Myeloma Fighters Information Group Michael Tuohy. SAVE MY SEAT.

Don’t miss IMF M-Power NYC Juneteenth 2025: Heritage, Health, and Hope—a powerful in-person event on Saturday, June 21, from 10:00 a.m - 12:15 p.m. EST. This workshop is designed to empower Black patients and families facing multiple myeloma. Hear directly from leading experts, including IMF Chief Medical Officer Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO (TGen, the City of Hope — Phoenix); Gail Panton, BSN, RN, CPN (Memorial Sloan Kettering Cancer Center  — New York); myeloma patient advocate Kathy Small Wrice; and IMF Scientific Advisory Board Member Saad Usmani, MD, MBA, FACP, FASCO (Memorial Sloan Kettering Cancer Center  — New York) Get your questions answered and connect with community. LEARN MORE. 

Join the IMF for a Seattle Community Workshop on August 9, 2025, at the Graduate by Hilton (4507 Brooklyn Ave NE).  Don’t miss this unique opportunity to connect with leading myeloma specialists in a supportive, in-person setting. 

During the event, experts will cover key topics, including myeloma basics, upfront treatments at diagnosis, maintenance therapy, and what to know about relapse. A member of the IMF Nurse Leadership Board will also provide insights on managing side effects and symptoms. Plus, attendees will have the opportunity to ask questions directly to the specialists. Click on the following link for updates on this event: REGISTER NOW.

The International Myeloma Foundation (IMF) is excited to announce that the 2025 Los Angeles Patient and Family Seminar will take place at the Hilton Los Angeles/Universal City (555 Universal Hollywood Drive) on August 15-16, 2025. IMF Team members who will speak at this seminar include IMF Vice President of Development Sylvia Dsouza; IMF Vice President of Support Groups Robin Tuohy; IMF Chief Medical Officer Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO; and twenty-five-year myeloma survivor Michael Tuohy. Additional myeloma experts and a keynote speaker will be announced soon. The seminar is FREE, but in-person seating is LIMITED. REGISTER NOW.